HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) major shareholder Of America Corp /De/ Bank acquired 670 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, July 26th. The shares were purchased at an average cost of $27.97 per share, with a total value of $18,739.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
HCA Healthcare Price Performance
HCA Healthcare stock opened at $342.25 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $84.26 billion, a P/E ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The firm has a fifty day moving average of $324.53 and a 200-day moving average of $341.25. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business earned $5.90 earnings per share. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Increases Dividend
Analyst Ratings Changes
Several equities research analysts recently commented on HCA shares. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada cut their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.
View Our Latest Analysis on HCA
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of HCA. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $31,000. Tidemark LLC bought a new position in HCA Healthcare during the 4th quarter valued at $36,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter worth about $39,000. Activest Wealth Management lifted its position in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its stake in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
- Five stocks we like better than HCA Healthcare
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 03/24 – 03/28
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Upcoming IPO Stock Lockup Period, Explained
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.